盐酸羟考酮缓释片用于癌痛治疗的滴定  

Hydrochloride oxycodone sustained-release tablet for titration in cancer pain management

作　　者：杨平 王昆[2] 

机构地区：[1]北京解放军海军总医院肿瘤科,北京市100048 [2]天津医科大学肿瘤医院疼痛治疗科

出　　处：《中国肿瘤临床》2015年第12期600-602,585,共3页Chinese Journal of Clinical Oncology

基　　金：卫生部医药卫生科技发展研究中心项目(编号:W2011BX038)资助~~

摘　　要：盐酸羟考酮缓释片作为一种新型的强阿片类镇痛药,镇痛效果确切、口服安全性高、不良反应轻微,持续应用可提高癌痛患者的生存质量,是临床治疗中重度癌痛的首选药物之一。针对盐酸羟考酮缓释片治疗癌痛的药理特点,近年国内外将其用于癌痛治疗过程中的剂量调整,取得了很好的效果,本文对此进行综述。Oxycodone sustained-release tablet is a new formulation of potent opioids, which are characterized by their exact anal-gesic effect, high safety for oral administration, and slight adverse drug reaction. Oxycodone improves the quality of life of patients with cancer pains and is among the selected drugs used for controlling moderate and severe cancer pains. Relief from prolonged pain is achieved by adjusting the dose of Oxycontin （oxycodone hydrochloride） sustained-release tablet according to its pharmacological char-acteristics. The details are reviewed in this article.

关 键 词：羟考酮缓释片 癌痛 滴定 

分 类 号：R730.5[医药卫生—肿瘤]